These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24946474)

  • 41. NAG level differences in panic disorder and agoraphobia.
    Garvey MJ; Noyes R
    J Anxiety Disord; 2005; 19(7):818-25. PubMed ID: 16076427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing the clinical utility of agoraphobia in the context of panic disorder.
    Schmidt NB; Cromer KR
    Depress Anxiety; 2008; 25(2):158-66. PubMed ID: 17351905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Panic-agoraphobic spectrum: reliability and validity of assessment instruments.
    Shear MK; Frank E; Rucci P; Fagiolini DA; Grochocinski VJ; Houck P; Cassano GB; Kupfer DJ; Endicott J; Maser JD; Mauri M; Banti S
    J Psychiatr Res; 2001; 35(1):59-66. PubMed ID: 11287057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further validation of a cognitive-behavioral model of generalized anxiety disorder: diagnostic and symptom specificity.
    Dugas MJ; Marchand A; Ladouceur R
    J Anxiety Disord; 2005; 19(3):329-43. PubMed ID: 15686860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polish versions of the ICIQ-FLUTS and the ICIQ-FLUTS LF: translation, adaptation, and validation of female-specific instruments for evaluation of lower urinary tract symptoms.
    Przydacz M; Dudek P; Chlosta P
    Int Urogynecol J; 2021 Dec; 32(12):3259-3265. PubMed ID: 33871667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].
    Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V
    Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Self-evaluation of obsessive-compulsive disorder. Adaptation and validation of two psychometric scales to the French version].
    Hantouche E; Guelfi JD
    Encephale; 1993; 19(3):241-8. PubMed ID: 8275910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Constraint and loneliness in agoraphobia: an empirical investigation.
    Pehlivanidis A; Koulis S; Papakostas Y
    Psychiatriki; 2014; 25(3):171-8. PubMed ID: 25367660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Quality of Life in Depression Scale (QLDS)--development of the scale and Polish adaptation].
    Majkowicz M; Zdun-Ryzewska A; Landowski J; de Walden-Gałuszko K; Podolska M
    Psychiatr Pol; 2013; 47(4):705-14. PubMed ID: 24946476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reliability and validity of the self-report version of the Panic Disorder Severity Scale in Korea.
    Lee EH; Kim JH; Yu BH
    Depress Anxiety; 2009; 26(8):E120-3. PubMed ID: 19373866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Body Shape Questionnaire-34 (BSQ) and Functionality Appreciation Scale (FAS) - pertinent body image screening tools: Creation and validation of Polish language versions.
    Yurtsever I; Matusiak Ł; Szepietowska M; Evans C; Szepietowski JC
    Sci Prog; 2022; 105(3):368504221117068. PubMed ID: 35929138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sympathetic reactivity in agoraphobic patients with and without personality disorders.
    Ekeberg Ø; Hedley L; Einvik G; Rostrup M; Hoffart A
    J Psychosom Res; 2003 May; 54(5):457-63. PubMed ID: 12726903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of lifetime mood and panic-agoraphobic spectrum symptoms on quality of life of patients with rheumatoid arthritis.
    Piccinni A; Maser JD; Bazzichi L; Rucci P; Vivarelli L; Del Debbio A; Catena M; Bombardieri S; Dell'Osso L
    Compr Psychiatry; 2006; 47(3):201-8. PubMed ID: 16635649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The fear of fear concept: evidence in favour of multidimensionality.
    Arrindell WA
    Behav Res Ther; 1993 Jun; 31(5):507-18. PubMed ID: 8333827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Internal Structure and Clinical Utility of the Anxiety Control Questionnaire-Revised (ACQ-R) Spanish Version.
    Osma J; Barrada JR; García-Palacios A; Navarro-Haro M; Aguilar A
    Span J Psychol; 2016 Oct; 19():E63. PubMed ID: 27692017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Validation of the Polish version of the symptom checklist-27-plus questionnaire].
    Kuncewicz D; Dragan M; Hardt J
    Psychiatr Pol; 2014; 48(2):345-58. PubMed ID: 25016771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychometric testing confirms that the Brazilian-Portuguese adaptations, the original versions of the Fear-Avoidance Beliefs Questionnaire, and the Tampa Scale of Kinesiophobia have similar measurement properties.
    de Souza FS; Marinho Cda S; Siqueira FB; Maher CG; Costa LO
    Spine (Phila Pa 1976); 2008 Apr; 33(9):1028-33. PubMed ID: 18427325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feared consequences of panic attacks in panic disorder: a qualitative and quantitative analysis.
    Raffa SD; White KS; Barlow DH
    Cogn Behav Ther; 2004; 33(4):199-207. PubMed ID: 15625794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Depersonalization and derealization during panic and hypnosis in low and highly hypnotizable agoraphobics.
    Van Dyck R; Spinhoven P
    Int J Clin Exp Hypn; 1997 Jan; 45(1):41-54. PubMed ID: 8991295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychometric properties of the panic disorder severity scale: clinician-administered and self-report versions.
    Wuyek LA; Antony MM; McCabe RE
    Clin Psychol Psychother; 2011; 18(3):234-43. PubMed ID: 21110405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.